Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEndocrine Sequellae of Pediatric Malignancies
The Endocrinologist, 09/03/09
Burns KC et al. – The cure rate for pediatric malignancies continues to increase, creating a growing population of childhood cancer survivors. This group of individuals is at risk for many long–term late effects secondary to their cancer therapy. Endocrine problems are among the most frequently encountered long–term effects in this population. These effects may be evident immediately upon completion of therapy or they may not be evident until many years later.
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia
Journal of Clinical Oncology, 11/09/09
Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
Journal of Clinical Oncology, 11/19/09
Sponsor
Article Search
Sponsor
Sponsor